scholarly article | Q13442814 |
P356 | DOI | 10.1177/019459989110500403 |
P953 | full work available at URL | http://journals.sagepub.com/doi/pdf/10.1177/019459989110500403 |
P698 | PubMed publication ID | 1762790 |
P2093 | author name string | M. B. Wang | |
A. Lichtenstein | |||
R. A. Mickel | |||
P2860 | cites work | Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer | Q34194434 |
NIH conference. New approaches to the immunotherapy of cancer using interleukin-2. | Q39641278 | ||
Immunology of head and neck cancers | Q40109770 | ||
Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapy | Q41622603 | ||
First place--Resident Clinical Science Award 1990. Suppression of lymphokine-activated killer cell cytotoxicity by a soluble factor produced by squamous tumors of the head and neck | Q41720182 | ||
Immunologic abnormalities in head and neck cancer. | Q42439127 | ||
Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck | Q44496715 | ||
Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer | Q44862608 | ||
Depressed natural killer cell activity in cervical lymph nodes containing focal metastatic squamous cell carcinoma | Q45250241 | ||
Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state. | Q54390127 | ||
Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity | Q67294248 | ||
Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study | Q68093427 | ||
The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer | Q68428612 | ||
Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma | Q68721742 | ||
A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes | Q68804520 | ||
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone | Q68815180 | ||
Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer | Q68830648 | ||
Natural cytotoxicity in draining lymph nodes of squamous cell cancer in the maxillofacial region | Q68981231 | ||
Miniaturization of the standard 51Cr release assay for long term follow-up of NK activity of individual mice | Q69644437 | ||
Kinetic analysis of the inhibition of natural killer (NK) activity by multiple populations of tumor-activated suppressor cells | Q69881877 | ||
The glomerular permeability determined by dextran clearance using Sephadex gel filtration | Q72021219 | ||
Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients | Q72771288 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | surgery | Q40821 |
head and neck squamous cell carcinoma | Q18348812 | ||
P304 | page(s) | 517-527 | |
P577 | publication date | 1991-10-01 | |
P1433 | published in | Otolaryngology—Head and Neck Surgery | Q2646730 |
P1476 | title | Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma | |
Hierarchical Immunosuppression of Regional Lymph Nodes in Patients with Head and Neck Squamous Cell Carcinoma | |||
P478 | volume | 105 |
Q41140197 | Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck |
Q74602642 | Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy |
Q35577740 | Covalent linking of proteins and cytokines to suture: Enhancing the immune response of head and neck cancer patients |
Q41103809 | Cytokine expression by head and neck squamous cell carcinomas |
Q38070999 | Emerging insights into head and neck cancer metastasis |
Q40867463 | Immunology of head and neck cancer: perspectives |
Q44295538 | Key architectural changes in tumor-negative lymph nodes from metastatic-free oral cancer patients are valuable prognostic factors |
Q73668570 | Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2 |
Q74828892 | Nodal metastases: predictive factors |
Q39115679 | Prospects for future studies in head and neck cancer |
Q36820724 | Survival, metastasis and recurrence of oral cancer in relation to pathological features |
Search more.